How to manage primary amyloidosisGERTZ, M. A.Leukemia. 2012, Vol 26, Num 2, pp 191-198, issn 0887-6924, 8 p.Article

Secondary amyloidosis (AA)GERTZ, M. A.Journal of internal medicine. 1992, Vol 232, Num 6, pp 517-518, issn 0954-6820Article

Amyloidosis : Recognition, confirmation, prognosis, and therapyGERTZ, M. A; LACY, M. Q; DISPENZIERI, A et al.Mayo Clinic proceedings. 1999, Vol 74, Num 5, pp 490-494, issn 0025-6196Article

Second malignancies after chemotherapy and transplantationGERTZ, M. A; NOËL, P; KYLE, R. A et al.Critical reviews in oncology/hematology. 1993, Vol 14, Num 2, pp 107-125, issn 1040-8428Article

Hemorrhagic cystitis complicating bone marrow transplantationLETENDRE, L; HOAGLAND, C; GERTZ, M. A et al.Mayo Clinic proceedings. 1992, Vol 67, Num 2, pp 128-130, issn 0025-6196Article

Phase II trial of α-tocopherol (vitamin E) in the treatment of primary systemic amyloidosisGERTZ, M. A; KYLE, R. A.American journal of hematology. 1990, Vol 34, Num 1, pp 55-58, issn 0361-8609Article

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosisGERTZ, M. A; KYLE, R. A.American journal of hematology. 1993, Vol 44, Num 2, pp 125-128, issn 0361-8609Article

Primary systemic amyloidosis : a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemiaGERTZ, M. A; KYLE, R. A; NOEL, P et al.Journal of clinical oncology. 1993, Vol 11, Num 5, pp 914-920, issn 0732-183XArticle

Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literatureGERTZ, M. A; KYLE, R. A.Mayo Clinic proceedings. 1986, Vol 61, Num 3, pp 218-223, issn 0025-6196Article

Amyloid polyneuropathy in two German-American families : a new transthyretin variant (Val 107)UEMICHI, T; GERTZ, M. A; BENSON, M. D et al.Journal of medical genetics. 1994, Vol 31, Num 5, pp 416-417, issn 0022-2593Article

Cardiac amyloidosisKYLE, R. A; GERTZ, M. A.International journal of cardiology. 1990, Vol 28, Num 2, pp 139-141, issn 0167-5273, 3 p.Article

Primary systemic amyloidosis ― a diagnostic primerGERTZ, M. A; KYLE, R. A.Mayo Clinic proceedings. 1989, Vol 64, Num 12, pp 1505-1519, issn 0025-6196, 15 p.Article

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis : a status reportGERTZ, M. A; LACY, M. Q; DISPENZIERI, A et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 5, pp 465-470, issn 0268-3369Article

Hepatic amyloidosis : Clinical appraisal in 77 patientsGERTZ, M. A; KYLE, R. A.Hepatology (Baltimore, Md.). 1997, Vol 25, Num 1, pp 118-121, issn 0270-9139Article

A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathyUEMICHI, T; GERTZ, M. A; BENSON, M. D et al.Journal of medical genetics. 1995, Vol 32, Num 4, pp 279-281, issn 0022-2593Article

Exocrine pancreatic insufficiency after allogeneic bone marrow transplantationMARINGHINI, A; GERTZ, M. A; DIMAGNO, E. P et al.International journal of pancreatology. 1995, Vol 17, Num 3, pp 243-247, issn 0169-4197Article

Amyloidosis : prognosis and treatmentGERTZ, M. A; KYLE, R. A.Seminars in arthritis and rheumatism. 1994, Vol 24, Num 2, pp 124-138, issn 0049-0172Article

Prognostic value of urinary protein in primary systemic amyloidosis (AL)GERTZ, M. A; KYLE, R. A.American journal of clinical pathology. 1990, Vol 94, Num 3, pp 313-317, issn 0002-9173Article

Myopathy in primary systemic amyloidosisGERTZ, M. A; KYLE, R. A.Journal of neurology, neurosurgery and psychiatry. 1996, Vol 60, Num 6, pp 655-660, issn 0022-3050Article

Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCTKUMAR, S. K; DINGLI, D; DISPENZIERI, A et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 12, pp 1013-1019, issn 0268-3369, 7 p.Article

A phase I study of ¹⁵³Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaDISPENZIERI, A; WISEMAN, G. A; PORRATA, L et al.Leukemia. 2005, Vol 19, Num 1, pp 118-125, issn 0887-6924, 8 p.Article

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateGERTZ, M. A; LACY, M. Q; LITZOW, M. R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 12, pp 1025-1031, issn 0268-3369, 7 p.Article

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemiaKUMAR, S; CHEN, M. G; GASTINEAU, D. A et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 10, pp 951-956, issn 0268-3369Article

Prognostic value of bone marrow angiogenesis in multiple myelomaRAJKUMAR, S. V; LEONG, T; GREIPP, P. R et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3111-3116, issn 1078-0432Article

Beta₂-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaRAJKUMAR, S. V; FONSECA, R; LACY, M. Q et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 12, pp 1261-1266, issn 0268-3369Article